Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Aclaris Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- 0 vs. Q1 2024
- Shares held
- 52.9M
- −1.59M (−2.9%) vs. Q1 2024
- Total value
- $58.1M
- −$9.31M (−13.8%) vs. Q1 2024
- New holders
- 24
- 20 more added
- Sold out
- 24
- 38 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −166,656−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −62,974−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −60,400−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −46,358−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −34,229−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −32,843−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −30,984−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −30,498−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −17,654−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,114−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −14,788−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −13,033−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −9,646−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −6,982−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −6,900−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,307−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −580−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −18,694−100.0% | Sold out |